James A Fagin, Memorial Sloan-Kettering Cancer Center, New York, USA. Abstract
James A. Fagin is Chief of the Endocrine Service and a Member of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center in New York, and a Professor of Medicine at Weill Medical College of Cornell University. He was formerly the James Heady Professor of Medicine and Director of the Division of Endocrinology and Metabolism at the University of Cincinnati. He has had a long standing interest in the pathogenesis of thyroid neoplasms, and his laboratory focuses on thyroid cancer genetics, on the development of mouse models to understand the biology of these tumors, and on the identification of specific therapies directed at key oncoproteins that drive the disease.
He was a member and then the chair of the NIH Endocrinology Study Section (19982002). In addition to serving on a number of Editorial Boards, he is a former Associate Editor of Endocrinology, former Editor (Americas) for Clinical Endocrinology (Oxford), and recently retired as Editor-in-Chief of Endocrine-Related Cancer. Dr. Fagin is a member of the American Society of Clinical Investigation and the Association of American Physicians. His honors include the Merck Prize of the European Thyroid Association, and the Sidney H. Ingbar Distinguished Lectureship Award of the American Thyroid Association. He is also the President-elect of the American Thyroid Association.